A non-bioabsorbable tubular device intended to be implanted in a peripheral artery (excludes aorta, coronary, pulmonary, and intracranial arteries) to maintain patency and improve luminal diameter, typically in patients with symptomatic peripheral vascular dis
| Company | Devices | Share |
|---|---|---|
| Atrium Medical Corporation | 52 | 40% |
| Clearstream Technologies Limited | 42 | 32% |
| W. L. Gore & Associates, Inc. | 35 | 27% |
| Bard Peripheral Vascular, Inc. | 1 | 1% |
Company = labeler of record on GUDID. 4 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| PFV | System, Endovascular Graft, Arteriovenous (Av) Dialysis Acce | 84 |
| NIP | Stent, Superficial Femoral Artery | 84 |
| PRL | Iliac Covered Stent, Arterial | 52 |
| PRL | Iliac covered stent, arterial | 42 |
| PFV | System, endovascular graft, arteriovenous (AV) dialysis acce | 31 |
Use these as the dimensions to specify in a tender line.
130 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Peripheral artery endovascular stent-graft, non-medicated", from 4 companies. The largest labeler is Atrium Medical Corporation with 40% of records.
PFV (System, Endovascular Graft, Arteriovenous (Av) Dialysis Acce), NIP (Stent, Superficial Femoral Artery), PRL (Iliac Covered Stent, Arterial), PRL (Iliac covered stent, arterial)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add peripheral artery endovascular stent-graft, non-medicated to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.